Viacor
About:
Viacor develops catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure.
Website: http://www.viacorinc.com
Top Investors: New Enterprise Associates, Canaan Partners
Description:
Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure (CHF).
Total Funding Amount:
$34M
Headquarters Location:
Wilmington, Massachusetts, United States
Founded Date:
1999-12-01
Contact Email:
info(AT)viacorinc.com
Founders:
Marc Gillinov, Todd Davenport
Number of Employees:
11-50
Last Funding Date:
2010-11-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai